Press Releases May 26, 2026 05:00 AM

Voting Results from Constellium's 2026 Annual General Meeting

Constellium SE announces successful voting results for board appointments at 2026 AGM

By Caleb Monroe CSTM

Constellium SE disclosed the voting outcomes from its 2026 Annual General Meeting, confirming the appointment of Ingrid Joerg and the re-appointment of John Ormerod to its Board of Directors for three-year terms. All proposals passed successfully, reinforcing the company's governance stability.

Voting Results from Constellium's 2026 Annual General Meeting
CSTM

Key Points

  • Ingrid Joerg appointed to the Board of Directors at Constellium SE.
  • John Ormerod re-appointed for another three-year term.
  • All AGM proposals were approved, reflecting shareholder support.

PARIS, May 26, 2026 (GLOBE NEWSWIRE) -- Constellium SE (NYSE: CSTM) announced the voting results for its Annual General Meeting of Shareholders held on May 21, 2026 (the “AGM”). The proposals for the appointment of Ingrid Joerg and the re-appointment of John Ormerod to the Company’s Board of Directors for a period of three years following the Annual General Meeting passed. The complete voting results on all proposals have been published on the Company’s website (https://www.constellium.com/investors/shareholder-meetings). 

About Constellium

Constellium (NYSE: CSTM) is a global sector leader that develops innovative, value-added aluminum products for a broad scope of markets and applications, including aerospace, packaging and automotive. Constellium generated $8.4 billion of revenue in 2025.

www.constellium.com

Media Contacts   Investor Relations CommunicationsJason Hershiser Delphine Dahan-KocherPhone: +1 443 988-0600 Phone: +1 443 420 [email protected] [email protected]



Risks

  • Potential governance risks if new board members do not align with shareholder interests.
  • Market uncertainties due to global economic factors impacting aluminum demand.
  • Risks related to automotive and aerospace sectors which are key markets for Constellium's products.

More from Press Releases

Eledon Announces Presentation of Updated Data from Investigator-Initiated Islet Transplant Trial of Tegoprubart in Patients with Type 1 Diabetes at American Diabetes Association (ADA) 2026 Scientific Sessions Jun 4, 2026 Xos Makes Its GFX Debut with Electric Vehicles, Powertrain Technology, and Mobile Charging for Public Fleets Jun 4, 2026 Satellogic to Participate in June Investor Conferences Jun 4, 2026 BIO GREEN MED SOLUTION, INC. ANNOUNCES BUSINESS COMBINATION AGREEMENT TO ACQUIRE FUTURE NRG SDN. BHD. Jun 4, 2026 SI-BONE To Present at Truist Securities 2026 MedTech Conference on June 16, 2026 Jun 4, 2026